🎀 Breast Imaging BI-RADS Category & Management
Look up the malignancy likelihood and standardised management for any ACR BI-RADS breast-imaging category (0–6). Instant, browser-side.
Clinical takeaway
Only categories 0/1/2 are used for screening; 3/4/5/6 follow a diagnostic work-up.
Loading calculator…
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
When to use
Translate an assigned BI-RADS category into the correct management pathway.
How it works
0 incomplete → additional imaging; 1/2 → routine screening; 3 (< 2%) → short-interval follow-up; 4A/4B/4C (2–95%) and 5 (≥ 95%) → biopsy; 6 → definitive treatment.
Key points
- Only categories 0/1/2 are used for screening; 3/4/5/6 follow a diagnostic work-up.
- Category 3 (probably benign) means malignancy < 2% and short-interval follow-up.
- A benign biopsy discordant with imaging in category 4C/5 needs further action.
- Category 4 is sub-divided 4A/4B/4C by the physician's malignancy estimate.
References
Decision support for licensed clinicians only; not a substitute for clinical judgement, diagnosis or local protocols.
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| BI-RADS category | 0 — Incomplete |
|---|
→ManagementAdditional imaging / prior comparison
- Category：BI-RADS 0: Incomplete assessment
- Management：Additional imaging (spot/magnification views, ultrasound) or comparison with priors, then assign a final category
- Note：BI-RADS management falls into four groups: additional imaging, routine screening, short-interval follow-up, biopsy; only 0/1/2 are used for screening, 3/4/5/6 after a diagnostic work-up
| BI-RADS category | 6 — Known biopsy-proven malignancy |
|---|
→ManagementDefinitive treatment
- Category：BI-RADS 6: Biopsy-proven malignancy
- Management：Definitive treatment (surgery/chemotherapy, etc.); imaging is used to assess treatment response
- Note：BI-RADS management falls into four groups: additional imaging, routine screening, short-interval follow-up, biopsy; only 0/1/2 are used for screening, 3/4/5/6 after a diagnostic work-up
Frequently asked questions
- What is Breast Imaging BI-RADS Category & Management?
- Look up the malignancy likelihood and standardised management for any ACR BI-RADS breast-imaging category (0–6). Instant, browser-side.
- How is Breast Imaging BI-RADS Category & Management calculated? What is the core formula?
- 0 incomplete → additional imaging; 1/2 → routine screening; 3 (< 2%) → short-interval follow-up; 4A/4B/4C (2–95%) and 5 (≥ 95%) → biopsy; 6 → definitive treatment.
- When is Breast Imaging BI-RADS Category & Management used?
- Translate an assigned BI-RADS category into the correct management pathway.
- What are the key clinical points for Breast Imaging BI-RADS Category & Management?
- Only categories 0/1/2 are used for screening; 3/4/5/6 follow a diagnostic work-up. Category 3 (probably benign) means malignancy < 2% and short-interval follow-up. A benign biopsy discordant with imaging in category 4C/5 needs further action. Category 4 is sub-divided 4A/4B/4C by the physician's malignancy estimate.
- What are the limits and cautions when using Breast Imaging BI-RADS Category & Management?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- How is Breast Imaging BI-RADS Category & Management calculated in practice? Can you show a worked example?
- Inputs: BI-RADS category 0 — Incomplete → Result: Management Additional imaging / prior comparison（Category: BI-RADS 0: Incomplete assessment, Management: Additional imaging (spot/magnification views, ultrasound) or comparison with priors, then assign a final category, Note: BI-RADS management falls into four groups: additional imaging, routine screening, short-interval follow-up, biopsy; only 0/1/2 are used for screening, 3/4/5/6 after a diagnostic work-up） Inputs: BI-RADS category 6 — Known biopsy-proven malignancy → Result: Management Definitive treatment（Category: BI-RADS 6: Biopsy-proven malignancy, Management: Definitive treatment (surgery/chemotherapy, etc.); imaging is used to assess treatment response, Note: BI-RADS management falls into four groups: additional imaging, routine screening, short-interval follow-up, biopsy; only 0/1/2 are used for screening, 3/4/5/6 after a diagnostic work-up）